Villere ST Denis J & Co. LLC Lowers Stock Position in Colgate-Palmolive Company $CL

Villere ST Denis J & Co. LLC trimmed its position in Colgate-Palmolive Company (NYSE:CL) by 3.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 227,880 shares of the company’s stock after selling 9,275 shares during the quarter. Colgate-Palmolive comprises approximately 2.1% of Villere ST Denis J & Co. LLC’s holdings, making the stock its 29th biggest position. Villere ST Denis J & Co. LLC’s holdings in Colgate-Palmolive were worth $19,422,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Brighton Jones LLC increased its stake in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares in the last quarter. Woodline Partners LP lifted its position in shares of Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after acquiring an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. boosted its stake in shares of Colgate-Palmolive by 2.0% in the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after acquiring an additional 245 shares during the period. Nebula Research & Development LLC grew its position in shares of Colgate-Palmolive by 165.5% during the second quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock worth $939,000 after purchasing an additional 6,437 shares in the last quarter. Finally, Sei Investments Co. grew its position in shares of Colgate-Palmolive by 21.7% during the second quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock worth $59,732,000 after purchasing an additional 116,968 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock traded up $1.30 on Friday, reaching $92.31. The company’s stock had a trading volume of 4,257,117 shares, compared to its average volume of 4,923,956. The stock’s fifty day simple moving average is $89.91 and its 200-day simple moving average is $88.10. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a market capitalization of $73.86 billion, a price-to-earnings ratio of 35.92, a price-to-earnings-growth ratio of 4.80 and a beta of 0.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same quarter in the prior year, the firm earned $0.91 earnings per share. Colgate-Palmolive’s revenue was up 8.4% on a year-over-year basis. Analysts forecast that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. The Goldman Sachs Group reissued a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Bank of America dropped their target price on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Sanford C. Bernstein initiated coverage on shares of Colgate-Palmolive in a research note on Thursday, June 11th. They set a “market perform” rating and a $96.00 target price for the company. Finally, Piper Sandler increased their price objective on shares of Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $96.29.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.